Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

As winter brings a rise in coughs, colds, and fevers, it’s often hard to tell if it’s just a seasonal viral, the flu, or ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

A new genomic method has enabled multiple people with rare conditions to receive diagnoses that were previously unattainable ...